Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


Anna Andrzejewska

Mossakowski Medical Research Centre, Poland

Title: Adhesion ability of human mesenchymal stem cells overexpressing VLA-4 molecules via MrnaITGA-4 transfection


Biography: Anna Andrzejewska


Introduction: Mesenchymal stem cells (MSCs) are of great interest in regenerative medicine. Their plasticity and low immunogenicity gains them credibility as therapeutic agents in tissue injured disorders. The success of clinical application of MSCs relies on their recruitment into damaged tissues. Systemic infusion of MSCs is minimally invasive method however cell migration into desired organs is inefficient. We hypothesize that induction of integrin overexpression in MSCs will enhance their adhesion and migration through the endothelial wall.


Aim: The goal of our study was to induce the expression of ITGA-4 (VLA-4 subunit) via mRNA based method and to test whether this overexpression leads to increased adhesion of human bone marrow derived MSCs (hBM-MSCs).


Methods: The naive and mRNA-ITGA4 transfected hBM-MSCs (Lonza) labeled with iron nanoparticles and Rhodamine-B was used. The microfluidic and transwell assays with surfaces coated with VCAM-1 were employed to estimate functionality of modified MSCs in vitro.


Results: In microfluidic assay MSCs were observed to roll, capture and arrest into microchannels. Quantitative analysis showed that the average flow speed of VLA-4 over-expressing MSCs was smaller (27.5 pixels/frame) than the flow of naive cells (76 pixels per frame). Also, the percentage of arrested MSCs was higher in case of modified cells than of control MSCs (14% vs. 2.8%). Similarly, in transwell assay we observed reduced migration of transfected MSCs compared to non-transfected cells.


Conclusions: Our in vitro studies have shown superior adhesive properties of mRNA-ITGA-4 engineered hBM-MSCs over their naive counterparts. Modification of adhesive proteins on MSCs surface seems to be interesting perspective in their clinical settings.